Matches in SemOpenAlex for { <https://semopenalex.org/work/W2192432404> ?p ?o ?g. }
- W2192432404 abstract "Immunosuppressive factors, such as soluble major histocompatibility complex class I chain-related peptide A (sMICA) and transforming growth factor beta 1 (TGF-β1), are involved in tumor immune escape mechanisms (TIEMs) exhibited by head and neck squamous cell carcinomas (HNSCCs) and may represent opportunities for therapeutic intervention. In order to overcome TIEMs, we investigated the antibody-dependent cellular cytotoxicity (ADCC), cytokine release and retargeted tumor infiltration of sMICA-inhibited patient NK cells expressing Fcγ receptor IIIa (FcγRIIIa, CD16a) in the presence of cetuximab, an anti-epidermal growth factor receptor (HER1) monoclonal antibody (mAb). Compared to healthy controls, relapsed HNSCC patients (n = 5), not currently in treatment revealed decreased levels of circulating regulatory NK cell subsets in relation to increased cytotoxic NK cell subpopulations. Elevated sMICA and TGF-β1 plasma levels correlated with diminished TNFα and IFN-γ release and decreased NKG2D (natural killer group 2 member D)-dependent killing of HNSCC cells by NK cells. Incubation of IL-2-activated patient NK cells with patient plasma containing elevated sMICA or sMICA analogs (shed MICA and recombinant MICA) significantly impaired NKG2D-mediated killing by down-regulation of NKG2D surface expression. Of note, CD16 surface expression levels, pro-apoptotic and activation markers, and viability of patient and healthy donor NK cell subpopulations were not affected by this treatment. Accordingly, cetuximab restored killing activity of sMICA-inhibited patient NK cells against cetuximab-coated primary HNSCC cells via ADCC in a dose-dependent manner. Rapid reconstitution of anti-tumor recognition and enhanced tumor infiltration of treated NK cells was monitored by 24 h co-incubation of HNSCC tumor spheroids with cetuximab (1 μg/ml) and was characterized by increased IFN-γ and TNFα secretion. This data show that the impaired NK cell-dependent tumor surveillance in relapsed HNSCC patients could be reversed by the re-establishment of ADCC-mediated effector cell activity, thus supporting NK cell-based immunotherapy in combination with antineoplastic monoclonal mAbs." @default.
- W2192432404 created "2016-06-24" @default.
- W2192432404 creator A5009342925 @default.
- W2192432404 creator A5009530347 @default.
- W2192432404 creator A5011083669 @default.
- W2192432404 creator A5012473798 @default.
- W2192432404 creator A5016512953 @default.
- W2192432404 creator A5039333998 @default.
- W2192432404 creator A5048086068 @default.
- W2192432404 creator A5052001856 @default.
- W2192432404 creator A5058053674 @default.
- W2192432404 creator A5064741787 @default.
- W2192432404 creator A5083922106 @default.
- W2192432404 date "2015-11-02" @default.
- W2192432404 modified "2023-09-30" @default.
- W2192432404 title "Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids" @default.
- W2192432404 cites W1505370951 @default.
- W2192432404 cites W1506139159 @default.
- W2192432404 cites W1541265927 @default.
- W2192432404 cites W1549291581 @default.
- W2192432404 cites W1551030049 @default.
- W2192432404 cites W1556867369 @default.
- W2192432404 cites W1686570062 @default.
- W2192432404 cites W181486121 @default.
- W2192432404 cites W1894510512 @default.
- W2192432404 cites W1953823780 @default.
- W2192432404 cites W1964368483 @default.
- W2192432404 cites W1968139996 @default.
- W2192432404 cites W1970527277 @default.
- W2192432404 cites W1972316552 @default.
- W2192432404 cites W1982019987 @default.
- W2192432404 cites W1985444402 @default.
- W2192432404 cites W1986134558 @default.
- W2192432404 cites W1992126368 @default.
- W2192432404 cites W1994261231 @default.
- W2192432404 cites W1994417017 @default.
- W2192432404 cites W1994538641 @default.
- W2192432404 cites W1997859032 @default.
- W2192432404 cites W2004408045 @default.
- W2192432404 cites W2008164090 @default.
- W2192432404 cites W2012023873 @default.
- W2192432404 cites W2012310044 @default.
- W2192432404 cites W2014349052 @default.
- W2192432404 cites W2018244685 @default.
- W2192432404 cites W2019629102 @default.
- W2192432404 cites W2019822903 @default.
- W2192432404 cites W2020288890 @default.
- W2192432404 cites W2021380914 @default.
- W2192432404 cites W2022580424 @default.
- W2192432404 cites W2023363524 @default.
- W2192432404 cites W2025635581 @default.
- W2192432404 cites W2026859850 @default.
- W2192432404 cites W2027536435 @default.
- W2192432404 cites W2028593992 @default.
- W2192432404 cites W2030177319 @default.
- W2192432404 cites W2034975420 @default.
- W2192432404 cites W2046790948 @default.
- W2192432404 cites W2051999609 @default.
- W2192432404 cites W2064229689 @default.
- W2192432404 cites W2064920472 @default.
- W2192432404 cites W2070727232 @default.
- W2192432404 cites W2075521813 @default.
- W2192432404 cites W2076890010 @default.
- W2192432404 cites W2082211942 @default.
- W2192432404 cites W2082421652 @default.
- W2192432404 cites W2091312795 @default.
- W2192432404 cites W2095690828 @default.
- W2192432404 cites W2096103793 @default.
- W2192432404 cites W2096205095 @default.
- W2192432404 cites W2098150432 @default.
- W2192432404 cites W2106632394 @default.
- W2192432404 cites W2112887207 @default.
- W2192432404 cites W2115037567 @default.
- W2192432404 cites W2116555647 @default.
- W2192432404 cites W2122766813 @default.
- W2192432404 cites W2125662786 @default.
- W2192432404 cites W2125711219 @default.
- W2192432404 cites W2130401210 @default.
- W2192432404 cites W2131801665 @default.
- W2192432404 cites W2138357033 @default.
- W2192432404 cites W2142864509 @default.
- W2192432404 cites W2144719044 @default.
- W2192432404 cites W2146100972 @default.
- W2192432404 cites W2146602833 @default.
- W2192432404 cites W2146906100 @default.
- W2192432404 cites W2150319141 @default.
- W2192432404 cites W2150950354 @default.
- W2192432404 cites W2159195088 @default.
- W2192432404 cites W2163196794 @default.
- W2192432404 cites W2168479321 @default.
- W2192432404 cites W2168518154 @default.
- W2192432404 cites W2171547355 @default.
- W2192432404 cites W2171709048 @default.
- W2192432404 cites W2181844200 @default.
- W2192432404 cites W2182455706 @default.
- W2192432404 cites W2264583710 @default.
- W2192432404 doi "https://doi.org/10.3389/fimmu.2015.00543" @default.
- W2192432404 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4629470" @default.
- W2192432404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26579120" @default.
- W2192432404 hasPublicationYear "2015" @default.